Clinical Translation of Mesenchymal Stem Cells to Medicinal Signaling Cells: Origins, Clinical Applications, and the Future of Regenerative Medicine-2026 Arnold I. Caplan Award for Distinguished Research in Orthobiologics.

DeFoor MT, Philippon MJ, Huard J

Open source

DOI
10.5435/jaaos-d-26-00882
Published
2026 Sep 30
Container
The Journal of the American Academy of Orthopaedic Surgeons
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.5435/jaaos-d-26-00882,
  title = {Clinical Translation of Mesenchymal Stem Cells to Medicinal Signaling Cells: Origins, Clinical Applications, and the Future of Regenerative Medicine-2026 Arnold I. Caplan Award for Distinguished Research in Orthobiologics.},
  author = {DeFoor MT and Philippon MJ and Huard J},
  year = {2026},
  journal = {The Journal of the American Academy of Orthopaedic Surgeons},
  doi = {10.5435/jaaos-d-26-00882},
  url = {https://doi.org/10.5435/jaaos-d-26-00882}
}

RIS

TY  - JOUR
TI  - Clinical Translation of Mesenchymal Stem Cells to Medicinal Signaling Cells: Origins, Clinical Applications, and the Future of Regenerative Medicine-2026 Arnold I. Caplan Award for Distinguished Research in Orthobiologics.
AU  - DeFoor MT
AU  - Philippon MJ
AU  - Huard J
PY  - 2026
JO  - The Journal of the American Academy of Orthopaedic Surgeons
DO  - 10.5435/jaaos-d-26-00882
UR  - https://doi.org/10.5435/jaaos-d-26-00882
ER  - 

APA

MT, D., MJ, P., & J, H. (2026). Clinical Translation of Mesenchymal Stem Cells to Medicinal Signaling Cells: Origins, Clinical Applications, and the Future of Regenerative Medicine-2026 Arnold I. Caplan Award for Distinguished Research in Orthobiologics.. The Journal of the American Academy of Orthopaedic Surgeons. https://doi.org/10.5435/jaaos-d-26-00882

Source records